Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Guanghui,Gao ^[1] ; Keyi,Jia ^[1] ; Sha,Zhao ^[1] ; Xuefei,Li ^[2] ; Chao,Zhao ^[2] ; Tao,Jiang ^[1] ; Chunxia,Su ^[1] ; Shengxiang,Ren ^[1] ; Fei,Zhou ^[1] ; Caicun,Zhou ^[1]

作者单位： Department of Medical Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China. ^[1] Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. ^[2]

关键词 Chemotherapy immune checkpoint inhibitors (ICIs)non-small cell lung cancer programmed cell death factor 1 programmed death ligand 1

DOI 10.21037/tlcr.2019.11.25

PMID 32010570

发布时间 2022-04-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational lung cancer research

2019年8卷6期

920-928页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

检索历史清除